platelet factor 4 and β-thromboglobulin mrnas in circulating microparticles of trauma patients as diagnostic markers for deep vein thrombosis

Deep vein thrombosis (dvt) is a common complication after trauma. the development of markers to predict dvt in trauma patients is needed, and circulating microparticles (mps) and their contents are possible candidates. in this study, we aimed to identify platelet factor 4 (pf4) and β-thromboglobulin (β-tg) mrnas in circulating mps as potential markers for dvt diagnosis in trauma patients. fifteen trauma patients diagnosed with dvt and fifteen matched patients without dvt were included in this study. fifteen healthy volunteers also were included as controls. circulating mps were obtained from the plasma of all study subjects. annexin v+ mps and platelet-derived mps (pmps) were quantified using flow cytometry. pf4 and β-tg mrnas in mps were determined by qpcr, and the common logarithm of relative quantitation (rq) was calculated using the comparative ct method. receiver-operating characteristic (roc) curves were performed to analyze the diagnostic value of pf4 and β-tg mrnas. no significant differences were found in annexin v+ mps and pmps levels between trauma patients with and without dvt. however, both pf4 and β-tg mrnas in mps from the dvt group were significantly higher than the non-dvt group and healthy controls (p = 0.014 for pf4, p = 0.010 for β-tg). the roc curve analysis showed that both the pf4 mrna (area-under curve (auc) 0.756, p = 0.017) and the β-tg mrna (auc 0.751, p = 0.019) had a positive predictive value for dvt. this finding indicates that the pf4 and β-tg mrnas in mps be used as potential biomarkers for dvt diagnosis in trauma patients.